Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Stoitzner

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Vaccines|May 7, 2025
Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of MelanomaAthanasios Seretis, Lukas Amon, Christoph H Tripp, et al.
The Journal of Investigative Dermatology|June 12, 2020
Notch-Mediated Generation of Monocyte-Derived Langerhans Cells: Phenotype and FunctionLydia Bellmann, Claudia Zelle-Rieser, Paul Milne, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 19, 2026
Targeting Langerhans cells using a modular mannosylated nucleic acid-based vaccine platformSimon Christian Vinther, Antonia Resag, Karina Thao Thu Le, et al.
European Journal of Immunology|December 21, 2021
Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C-type lectin receptor LangerinLydia Bellmann, Helen Strandt, Claudia Zelle-Rieser, et al.
Inflammation and Regeneration|October 31, 2023
Preadipocytes in human granulation tissue: role in wound healing and response to macrophage polarizationTina Rauchenwald, Florian Handle, Catherine E Connolly, et al.
Nature Cancer|March 29, 2025
Systemic rewiring of dendritic cells by melanoma-secreted midkine impairs immune surveillance and response to immune checkpoint blockadeXavier Catena, Marta Contreras-Alcalde, Naiara Juan-Larrea, et al.
Nature Communications|March 14, 2024
Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumorsLucía López, Luciano Gastón Morosi, Federica La Terza, et al.
Journal for Immunotherapy of Cancer|January 7, 2021
Skin dendritic cells in melanoma are key for successful checkpoint blockade therapyAnastasia Prokopi, Christoph H Tripp, Bart Tummers, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanomaFlorian Hornsteiner, Janine Vierthaler, Helen Strandt, et al.
Journal for Immunotherapy of Cancer|June 30, 2026
Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanomaSophie Marie Dieckmann, Christoph H Tripp, Helen Strandt, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Vaccines|May 7, 2025
Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of MelanomaAthanasios Seretis, Lukas Amon, Christoph H Tripp, et al.
The Journal of Investigative Dermatology|June 12, 2020
Notch-Mediated Generation of Monocyte-Derived Langerhans Cells: Phenotype and FunctionLydia Bellmann, Claudia Zelle-Rieser, Paul Milne, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 19, 2026
Targeting Langerhans cells using a modular mannosylated nucleic acid-based vaccine platformSimon Christian Vinther, Antonia Resag, Karina Thao Thu Le, et al.
European Journal of Immunology|December 21, 2021
Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C-type lectin receptor LangerinLydia Bellmann, Helen Strandt, Claudia Zelle-Rieser, et al.
Inflammation and Regeneration|October 31, 2023
Preadipocytes in human granulation tissue: role in wound healing and response to macrophage polarizationTina Rauchenwald, Florian Handle, Catherine E Connolly, et al.
Nature Cancer|March 29, 2025
Systemic rewiring of dendritic cells by melanoma-secreted midkine impairs immune surveillance and response to immune checkpoint blockadeXavier Catena, Marta Contreras-Alcalde, Naiara Juan-Larrea, et al.
Nature Communications|March 14, 2024
Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumorsLucía López, Luciano Gastón Morosi, Federica La Terza, et al.
Journal for Immunotherapy of Cancer|January 7, 2021
Skin dendritic cells in melanoma are key for successful checkpoint blockade therapyAnastasia Prokopi, Christoph H Tripp, Bart Tummers, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanomaFlorian Hornsteiner, Janine Vierthaler, Helen Strandt, et al.
Journal for Immunotherapy of Cancer|June 30, 2026
Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanomaSophie Marie Dieckmann, Christoph H Tripp, Helen Strandt, et al.
Pageof 10